Controlled-release nanoencapsulating microcapsules to combat inflammatory diseases

The World Health Organization (WHO) has reported that globally 235 million people suffer from chronic and other inflammatory diseases. The short half-lives of nonsteroidal anti-inflammatory drugs (NSAIDs) and their notoriety in causing gastrointestinal discomforts, warrants these drugs to be release...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Jong-Suep, Yeo, Eng Wan, Lee, Yin Hao, Tan, Nguan Soon, Loo, Say Chye Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472418/
https://www.ncbi.nlm.nih.gov/pubmed/28652708
http://dx.doi.org/10.2147/DDDT.S133344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472418/
https://www.ncbi.nlm.nih.gov/pubmed/28652708
http://dx.doi.org/10.2147/DDDT.S133344

Ejemplares similares